Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
DOI

10.1186/bcr2748

Type

Journal article

Journal

Breast Cancer Res

Publication Date

20/12/2010

Volume

12 Suppl 4

Keywords

Angiogenesis Inhibitors, Animals, Antibodies, Monoclonal, Antibodies, Monoclonal, Humanized, Bevacizumab, Breast Neoplasms, Female, Humans, Hypoxia-Inducible Factor 1, Intercellular Signaling Peptides and Proteins, Mice, Neovascularization, Pathologic, Pericytes, Polymorphism, Single Nucleotide, Signal Transduction, Vascular Endothelial Growth Factor A